Monday, 2 Mar 2026
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • House
  • ScienceAlert
  • VIDEO
  • White
  • man
  • Trumps
  • Watch
  • Season
  • star
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Tech and Science > ‘Ozempic’ For Cats Is Coming, And Vets Are Testing It on Overweight Pets : ScienceAlert
Tech and Science

‘Ozempic’ For Cats Is Coming, And Vets Are Testing It on Overweight Pets : ScienceAlert

Last updated: December 11, 2025 7:35 am
Share
‘Ozempic’ For Cats Is Coming, And Vets Are Testing It on Overweight Pets : ScienceAlert
SHARE

Revolutionary Weight Loss Drug for Overweight Cats in the Works

Recent estimates suggest that more than half of the world’s pet cats are overweight, posing serious health risks for these beloved feline companions. To address this growing concern, OKAVA Pharmaceuticals has initiated a groundbreaking clinical trial to evaluate the safety and efficacy of its innovative weight loss drug implant system, OKV-119.

Obesity in cats is often attributed to free feeding practices, where cats have unrestricted access to food throughout the day. This unhealthy eating habit can lead to a range of health issues, including osteoarthritis, diabetes mellitus, and cardiovascular problems. Managing feline obesity can be challenging, as rapid weight loss can result in severe conditions like hepatic lipidosis.

OKAVA’s drug implant, designed to be placed just below the cat’s skin, releases a controlled dose of the drug over a period of up to six months. Similar to human weight loss medications like Ozempic and Wegovy, OKV-119 is a GLP-1 receptor agonist that mimics the body’s natural satiety hormones and helps regulate blood sugar levels.

CEO Michael Klotsman emphasizes that OKV-119 is engineered to simulate the physiological effects of fasting, such as improved insulin sensitivity and reduced fat mass, without disrupting the cat’s regular feeding routine or the bond between pet and owner.

close-up portrait of a very overweight grey and white short-haired cat walking across grass
A few extra kilos can seriously affect a cat’s quality of life. (dennisvdw/Getty Images)

While the initial results from the clinical trials are promising, with one cat receiving the drug implant, further research is necessary to determine the drug’s effectiveness in treating obesity in cats. Previous studies have demonstrated the safety of the implant system in healthy cats, paving the way for more extensive trials.

See also  Wordware raises $30 million to make AI development as easy as writing a document

As we await the outcomes of these trials, experts recommend implementing strategies to promote healthy eating habits for cats, such as mealtime feeding and using enrichment toys to stimulate physical activity. With advancements in veterinary medicine, overweight cats may soon have access to a revolutionary weight loss solution that could improve their overall health and well-being.

TAGGED:CatsComingoverweightOzempicPetsScienceAlerttestingVets
Share This Article
Twitter Email Copy Link Print
Previous Article Best Men’s Loafers 2025 | Top 10 Style Picks Best Men’s Loafers 2025 | Top 10 Style Picks
Next Article The EPA website got the basics of climate science right. Until last week. The EPA website got the basics of climate science right. Until last week.
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

Puerto Rican Painter and NYC Arts Advocate Tony Bechara Dies at 83

Painter and printmaker Tony Bechara, a prominent figure in New York City's art scene, passed…

April 25, 2025

Here’s What to Expect From International Business Machines’ Next Earnings Report

Armonk, New York-based International Business Machines Corporation (IBM) is a global technology and consulting company…

January 8, 2026

Coinbase Takes Major Step Towards Super App Ambition With Banking License Application

Benzinga and Yahoo Finance LLC may receive a commission or revenue from specific items through…

October 12, 2025

CVS Health Path Forward Becomes Clearer And Breakup Is Unlikely

Cold Water on CVS Health Breakup Rumors: CEO David Joyner Commits to Improving Diversified Portfolio…

November 13, 2024

David Hasselhoff’s Ex-Wife Pamela Bach Dead By Suicide

Pamela Bach, the ex-wife of David Hasselhoff, tragically passed away by suicide at the age…

March 6, 2025

You Might Also Like

Samsung Galaxy S26 Ultra Privacy Display Issue Reported
Tech and Science

Samsung Galaxy S26 Ultra Privacy Display Issue Reported

March 2, 2026
Rubin Observatory has started paging astronomers 800,000 times a night
Tech and Science

Rubin Observatory has started paging astronomers 800,000 times a night

March 2, 2026
New Scientist recommends the quantum soundscape of Liminals
Tech and Science

New Scientist recommends the quantum soundscape of Liminals

March 2, 2026
Semaglutide May Reverse Damage Caused by Osteoarthritis, Study Suggests : ScienceAlert
Tech and Science

Semaglutide May Reverse Damage Caused by Osteoarthritis, Study Suggests : ScienceAlert

March 1, 2026
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?